Abstract
BRCA2 is a tumor suppressor gene involved in mammary tumorigenesis. Although important functions have been assigned to a few conserved domains of BRCA2, little is known about the longest internal conserved domain encoded by exons 14–24. We identified a novel protein, designated BCCIPα, that interacts with part of the internal conserved region of human BRCA2. Human BCCIP represents a family of proteins that are evolutionarily conserved, and contain three distinct domains: an N-terminus acidic domain (NAD) of 30–60 amino acids, an internal conserved domain (ICD) of 180–220 amino acids, and a C-terminus variable domain (CVD) of 30–60 amino acids. The N-terminal half of the human BCCIP ICD shares moderate homology with regions of calmodulin and M-calpain, suggesting that BCCIP may also bind Ca. Human cells express both a longer, BCCIPα, and a shorter, BCCIPβ, form of the protein, which differ in their CVD. BCCIP is a nuclear protein highly expressed in testis. Although BCCIPβ expression is relatively consistent in cancer cells, the expression of BCCIPα varies in cancer cell lines. The BCCIPα gene is located at chromosome 10q25.3–26.2, a region frequently altered in brain and other cancers. Furthermore, expression of BCCIPα inhibits breast and brain cancer cell growth, but fails to inhibit HT1080 cells and a non-transformed human skin fibroblast. These results suggest that BCCIPα is an important cofactor for BRCA2 in tumor suppression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- GST:
-
glutathion S-transferase
- BCCIP:
-
Brca2, Ca and Cip1 interacting protein
- DAPI:
-
4′, 6-diamidino-2-phenylindole
- NAD:
-
N-terminus acidic domain
- ICD:
-
internal conserved domain
- CVD:
-
C-terminus variable domain
- HSF:
-
human skin fibroblast
- FISH:
-
fluorescent in situ hybridization
References
Bignell G, Micklem G, Stratton MR, Ashworth A and Wooster R. . 1997 Hum. Mol. Genet. 6: 53–58.
Chen CF, Chen PL, Zhong Q, Sharp ZD and Lee WH. . 1999 J. Biol. Chem. 274: 32931–32935.
Gayther SA and Ponder BA. . 1998 Dis. Markers 14: 1–8.
Ittmann M. . 1996 Cancer Res. 56: 2143–2147.
Katagiri T, Saito H, Shinohara A, Ogawa H, Kamada N, Nakamura Y and Miki Y. . 1998 Genes Chrom. Cancer 21: 217–222.
Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Hong WK and Mao L. . 1998 Oncogene 17: 1749–1753.
Koul A, Nilbert M, Borg A, Cole BF and Arrick BA. . 1999 Genes Chrom. Cancer 24: 207–212.
Li W, Hesabi B, Babbo A, Pacione C, Liu J, Chen DJ, Nickoloff JA and Shen Z. . 2000 Nucleic Acids Res. 28: 1145–1153.
Maier D, Comparone D, Taylor E, Zhang Z, Gratzl O, Van Meir EG, Scott RJ and Merlo A. . 1997 Oncogene 15: 997–1000.
Marmorstein LY, Ouchi T and Aaronson SA. . 1998 Proc. Natl. Acad. Sci. USA 95: 13869–13874.
Milner J, Ponder B, Hughes-Davies L, Seltmann M and Kouzarides T. . 1997 Nature 386: 772–773.
Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A and Poustka A. . 1997 Nat. Genet. 17: 32–39.
Nordling M, Karlsson P, Wahlstrom J, Engwall Y, Wallgren A and Martinsson T. . 1998 Cancer Res. 58: 1372–1375.
Pear WS, Scott ML and Nolan GP. . 1997 Gene Therapy Protocols. Robbins PD (ed.). Humana Press: Totowa, New Jersey pp 41–57.
Peiffer SL, Herzog TJ, Tribune DJ, Mutch DG, Gersel, DJ and Goodfellow PJ. . 1995 Cancer Res. 55: 1922–1926.
Petersen S, Rudolf J, Bockmuhl U, Gellert K, Wolf G, Dietel M and Petersen I. . 1998 Oncogene 17: 449–454.
Pontremoli S, Melloni E and Salamino F. . 1999 Calcium as a Cellular Regulator. Carafoli E and Klee C (eds). Oxford University Press: New York pp 371–388.
Rasheed BK and Bigner SH. . 1991 Cancer Metastasis Rev. 10: 289–299.
Rasheed BK, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD and Bigner SH. . 1995 Oncogene 10: 2243–2246.
Robertson GP, Herbst RA, Nagane M, Huang HJ and Cavenee WK. . 1999 Cancer Res. 59: 3596–3601.
Sharan SK and Bradley A. . 1997 Genomics 40: 234–241.
Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, Sands A, Eichele G, Hasty P and Bradley A. . 1997 Nature 386: 804–810.
Shen Z, Pardington-Purtymun PE, Comeaux JC, Moyzis RK and Chen DJ. . 1996a Genomics 36: 271–279.
Shen Z, Peterson SR, Comeaux JC, Zastrow D, Moyzis RK, Bradbury EM and Chen DJ. . 1996b Mutat Res. 364: 81–89.
Shinohara A, Ogawa H, Matsuda Y, Ushio N, Ikeo K and Ogawa T. . 1993 Nat. Genet. 4: 239–243.
Spain BH, Larson CJ, Shihabuddin LS, Gage FH and Verma IM. . 1999 Proc. Natl. Acad. Sci. USA 96: 13920–13925.
Steck PA, Lin H, Langford LA, Jasser SA, Koul D, Yung WK and Pershouse MA. . 1999 Genes Chrom. Cancer 24: 135–43.
Tan TL, Essers J, Citterio E, Swagemakers SM, de Wit J, Benson FE, Hoeijmakers JH and Kanaar R. . 1999 Curr. Biol. 9: 325–328.
Tanabe S, Akiba T, Katoh M and Satoh T. . 1999 Pediatr. Int. 41: 565–567.
Taysi K, Strauss AW, Yang V, Padmalatha C and Marshall RE. . 1982 Ann. Genet. 25: 141–144.
Vidal M. . 1997 The Yeast Two-Hybrid System. Bartel PL and Fields S (eds). Oxford University Press: New York pp109–147.
Waggoner DJ, Chow CK, Dowton SB and Watson MS. . 1999 Am. J. Med. Genet. 86: 1–5.
Walker GJ, Palmer JM, Walters MK and Hayward NK. . 1995 Genes Chrom. Cancer 12: 134–141.
Wong AKC, Pero R, Ormonde PA, Tavtigian SV and Bartel PL. . 1997 J. Biol. Chem. 272: 31941–31944.
Yano K, Morotomi K, Saito H, Kato M, Matsuo F and Miki Y. . 2000 Biochem. Biophys. Res. Commun. 270: 171–175.
Yjandra N, Bax A, Crivici A and Ikura M. . 1999 Calcium as a Cellular Regulator. Carafoli, E. & Klee, C. (eds). Oxford University Press: New York pp 152–170.
Yuan SS, Lee SY, Chen G, Song M, Tomlinson GE and Lee EY. . 1999 Cancer Res. 59: 3547–3551.
Acknowledgements
We thank Drs Jac Nickoloff and Mark Brenneman for reviewing the manuscript and discussions. This research was supported by NIH NIEHS grant ES08353 and US Army Medical Research and Material Command under DAMD 17-98-1-8198. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of these funding agencies.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, J., Yuan, Y., Huan, J. et al. Inhibition of breast and brain cancer cell growth by BCCIPα, an evolutionarily conserved nuclear protein that interacts with BRCA2. Oncogene 20, 336–345 (2001). https://doi.org/10.1038/sj.onc.1204098
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204098
Keywords
This article is cited by
-
Roles of BCCIP deficiency in mammary tumorigenesis
Breast Cancer Research (2017)
-
Identification of translationally controlled tumor protein in promotion of DNA homologous recombination repair in cancer cells by affinity proteomics
Oncogene (2017)
-
Regulation of spindle integrity and mitotic fidelity by BCCIP
Oncogene (2017)
-
High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma
Digestive Diseases and Sciences (2017)
-
Expression of F-actin-capping protein subunit beta, CAPZB, is associated with cell growth and motility in epithelioid sarcoma
BMC Cancer (2016)